Triethylene Glycol

Triethylene Glycol

SCHEMBL275016

CC(=O)O.CCCCOCCCC.OCCOCCOCCO

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Triethylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.74
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
THRB P10828 1/20 0.65
HTT P42858 1/20 0.65
MAPT P10636 1/20 0.65
CYP3A4 P08684 2/20 0.47
ALDH1A1 P00352 3/20 0.46
CES2 O00748 1/20 0.45
MAPK1 P28482 2/20 0.44
RARB P10826 2/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
CASP1 P29466 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLCO1B3 Q9NPD5 1/20 0.44
SLCO1B1 Q9Y6L6 1/20 0.44
ACHE P22303 1/20 0.41
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL8327649 1.00 TSHR (0.74) TSHRMEN1KMT2ATHRBHTT
Acetic Acid SCHEMBL2516099 1.00 TSHR (0.74) TSHRMEN1KMT2ATHRBHTT
Acetic Acid SCHEMBL28870592 1.00 TSHR (0.74) TSHRMEN1KMT2ATHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL4453213 0.98 TSHR (0.77) TSHRMEN1KMT2ATHRBHTT
Butoxyethanol SCHEMBL587577 0.98 TSHR (0.77) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL19064944 0.94 MEN1 (0.76) TSHRMEN1KMT2ATHRBHTT
Acetic Acid SCHEMBL28282676 0.94 MEN1 (0.76) TSHRMEN1KMT2ATHRBHTT
Butoxyethanol SCHEMBL26126895 0.92 TSHR (0.68) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL19064978 0.92 MEN1 (0.80) TSHRMEN1KMT2ATHRBHTT
Acetic Acid SCHEMBL28282561 0.91 MEN1 (0.72) TSHRMEN1KMT2ATHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116652174-A Copper nanomaterial and preparation method and application thereof 深圳先进电子材料国际创新研究院 2023-08-29 CN claimed
CN-116652447-A Preparation method of copper-based solder paste for one-step bonding and bonding method thereof 深圳先进电子材料国际创新研究院 2023-08-29 CN claimed
CN-116638093-A Synthesis method of copper nano-particles with oxidation resistance 深圳先进电子材料国际创新研究院 2023-08-25 CN claimed
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-07 US disclosed
EP-4700824-A1 LOW-TEMPERATURE-SINTERING BONDING MATERIAL AND BONDED STRUCTURE Daicel Corporation (JP) 2026-02-25 EP disclosed
US-12473448-B2 Recording method, and ink composition used in recording method DNP FINE CHEMICALS CO., LTD. (JP) 2025-11-18 US disclosed
EP-4012726-B1 ADHESIVE CONDUCTIVE PASTE DAICEL CORP (JP) 2025-10-22 EP disclosed
US-12338356-B2 Nonaqueous ink composition, and recording method and recorded matter manufacturing method using same DNP FINE CHEMICALS CO., LTD. (JP) 2025-06-24 US disclosed
WO-2025088985-A1 QUANTUM DOT BODY, QUANTUM DOT COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL AND PRODUCTION METHOD THEREOF 信越化学工業株式会社 2025-05-01 WO disclosed
US-20250025604-A1 3D-PRINTABLE BIOCOMPOSITES NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2025-01-23 US disclosed
WO-2024241965-A1 QUANTUM DOT-CONTAINING COMPOSITION, WAVELENGTH CONVERSION MEMBER, AND METHOD FOR PRODUCING QUANTUM DOT-CONTAINING COMPOSITION 信越化学工業株式会社 2024-11-28 WO disclosed
CN-100347611-C Photosensitive resin composition, method for producing pattern and electronic parts HITACHI CHEMICAL CO LTD (JP) 2007-11-07 CN disclosed
US-7255737-B2 Organic formulations of pigment LANXESS DEUTSCHLAND GMBH (DE) 2007-08-14 US disclosed
US-20070017416-A1 Organic pigments for colour filters LANXESS DEUTSCHLAND GMBH 2007-01-25 US disclosed
US-20050241532-A1 Organic formulations of pigment LANXESS DEUTSCHLAND GMBH (DE) 2005-11-03 US disclosed
US-6849385-B2 Photosensitive resin composition, process of forming patterns with the same, and electronic components HITACHI CHEMICAL CO., LTD. (JP) 2005-02-01 US disclosed
US-20040180286-A1 Photosensitive resin composition, process of forming patterns with the same, and electronic components HITACHI CHEMICAL CO., LTD. (JP) 2004-09-16 US disclosed
CN-1522388-A Photosensitive resin composition, method for producing pattern and electronic parts 日立化成工业株式会社 2004-08-18 CN disclosed
US-6596446-B2 Used in in printing inks BAYER AKTIENGESELLSCHAFT (DE) 2003-07-22 US disclosed
US-20020034696-A1 Organic pigments in color filters of liquid crystal display LANXESS DEUTSCHLAND GMBH (DE) 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME ITGA6, STRA6, ILK TSHR 1369/4885MEN1 4558/4885KMT2A 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.